Losartan for the Treatment of Pediatric NAFLD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Diego
San Diego, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern Univ-Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- St. Louis University
St Louis, Missouri, United States
- Columbia University
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Oct 2018
- Primary completion
- 30 Jun 2020
- Completion
- 30 Jun 2020
- Last update posted
- 21 Oct 2021
- Registered enrollment
- 83
- Registry id
- NCT03467217
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.